spacer
home > ebr > spring 2002 > canada - the number one country for conducting biomedical r&d
PUBLICATIONS
European Biopharmaceutical Review

Canada - The Number One Country for Conducting Biomedical R&D

While lower cost is a compelling reason for conducting R&D in Canada, it is just one of several. Other factors include:

Canada is home to one of the largest, most developed biotech sectors in the world

The potential for partnerships with biotech firms undertaking cutting edge R&D exists throughout Canada

Government funding and tax credits for R&D is generous

Regulations are science-based and conducive to commercialising new products

Social and demographic features make Canada an excellent place to conduct clinical trials

Market-size is enormous, since Canada as a member of the North American Free Trade Agreement (NAFTA) has increased access to both the US and Mexican marketplace


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Michael Rappaport, Publications Supervisor at BIOTECanada Michael Rappaport is the Editor of BIOTECanada Insights, a bilingual, biannual magazine designed to promote the Canadian biotech sector, and BIOTECanada Monthly Reporter, an industry newsletter that provides updates on government relations activities and communications initiatives. Before assuming the position of Publications Supervisor at BIOTECanada, Michael was a Science Writer for the Natural Science and Engineering Research Council, the main funding body for biological, chemical, physical and engineering sciences in Canada. He has a BA Honours degree in English Literature and Political Science, and a Master of Journalism from Carleton University in Ottawa.
spacer
Michael Rappaport
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Vaisala Introduces CAB100 Industrial Cabinet for Cleanrooms

Vaisala, a global leader in weather, environmental, and industrial measurements, launches its newest offering for centralized environmental monitoring in cleanrooms: The CAB100 integrates Vaisala’s world-class instruments for monitoring parameters into a simple, pre-configured enclosure.
More info >>

White Papers

Nasal Drug Delivery with a Focus on Chronic Rhino-Sinusitis

Aptar Pharma

Aptar Pharma have hosted a scientific roundtable on “Nasal drug delivery with a focus on chronic rhino‑sinusitis”. This international scientific forum was held in Paris, France on November 13th 2012. The roundtable was organized to explore and exchange views on the science of various forms of sinusitis and its related unmet medical needs.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement